SABS
SAB BIOTHERAP (SABS)
NASDAQ
$3.75+$0.18 (+5.15%)
Price as of Aug 03, 2026 8:32 AM EDT
  • $273.0M
    Market Cap
  • 60.09%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
No data found

No data found

Momentum Score

Score: 54
Valuation
SABS
vs History
vs S&P 500
3-Month Momentum
9.92%
12-Month Momentum
106.38%
3-Month Risk Adjusted Momentum
31.60%
12-Month Risk Adjusted Momentum
145.54%

True Yield

N/A
Valuation
SABS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
0.60%

Financial Health Score

N/A
No data found

No data found